Загрузка...
Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran
BACKGROUND: A new group of oral anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban) with clear advantages over classic dicoumarin oral anticoagulants (warfarin and acenocoumarol) has been developed in recent years. Patients being treated with oral anticoagulants are at higher risk for bl...
Сохранить в:
| Опубликовано в: : | J Clin Exp Dent |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medicina Oral S.L.
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5303333/ https://ncbi.nlm.nih.gov/pubmed/28210451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4317/jced.53219 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|